Form 8-K - Current report:
SEC Accession No. 0001615774-15-003021
Filing Date
2015-10-26
Accepted
2015-10-26 09:25:47
Documents
3
Period of Report
2015-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s102057_form8k.htm 8-K 11299
2 EXHIBIT 10.1 s102057_exhibit10-1.htm EX-10.1 167595
3 EXHIBIT 10.2 s102057_exhibit10-2.htm EX-10.2 63514
  Complete submission text file 0001615774-15-003021.txt   243729
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 151174323
SIC: 8731 Services-Commercial Physical & Biological Research